Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab 📰 Read this top mentioned article on inflammatory bowel disease 👇 https://t.co/iLK3PiweMz https://t.co/JQ6m1xxuft
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab 📰 Read this top mentioned article on inflammatory bowel disease 👇 https://t.co/Y5Clxy9StZ https://t.co/wsJnXLpdim
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab 📰 Read this top mentioned article on inflammatory bowel disease 👇 https://t.co/5HaUiE9MzF https://t.co/kodjEl2lBv
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab 📰 Read this top mentioned article on inflammatory bowel disease 👇 https://t.co/evZrFecop6 https://t.co/POURg0xcRS
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTKYRk @Gut_B…
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTKYRk @Gut_B…
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTKYRk @Gut_B…
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTKYRk @Gut_B…
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTKYRk @Gut_BMJ
@clarityibd @VIPStudy1 @GUTJournal_BMJ The first big publication from CLARITY Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab 7000 patients with IBD on IFX or VEDO were recruited across the UK in the 10 wee
@JakePyne @Sflecce Time will tell I guess. https://t.co/R3G1LubIJG
@Methadone_Cat @Sflecce Probably not. My kids had N95s, but their classmates did not. Kids had to eat indoors, altho mine did so as rarely as possible. It was a matter of (very little) time. https://t.co/R3G1LubIJG
RT @Gut_BMJ: In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody respon…
RT @clarityibd: 📣😄Here is a FESTIVE 🔔 CHEER to YOU 😄📣 🔔 all the CLARITY research teams across the UK - YOU have WORKED so HARD 🔔IBD pati…
RT @clarityibd: 📣😄Here is a FESTIVE 🔔 CHEER to YOU 😄📣 🔔 all the CLARITY research teams across the UK - YOU have WORKED so HARD 🔔IBD pati…
RT @clarityibd: 📣😄Here is a FESTIVE 🔔 CHEER to YOU 😄📣 🔔 all the CLARITY research teams across the UK - YOU have WORKED so HARD 🔔IBD pati…
RT @clarityibd: 📣😄Here is a FESTIVE 🔔 CHEER to YOU 😄📣 🔔 all the CLARITY research teams across the UK - YOU have WORKED so HARD 🔔IBD pati…
📣😄Here is a FESTIVE 🔔 CHEER to YOU 😄📣 🔔 all the CLARITY research teams across the UK - YOU have WORKED so HARD 🔔IBD patients 🙌🙌 you ARE AMAZING - research is nothing without you giving up your time. Thank you so much 😊 #nihrresearch #ibdresearch http
RT @Gut_BMJ: In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody respon…
RT @Gut_BMJ: In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody respon…
RT @Gut_BMJ: In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody respon…
RT @Gut_BMJ: In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody respon…
RT @Gut_BMJ: In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody respon…
RT @Gut_BMJ: In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody respon…
In no particular order, the 5th paper selected as part of the #GUTBestPapers2021 countdown is "Anti-SARS-CoV-2 antibody responses are attenuated in patients with #IBD treated with IFX" - read via https://t.co/xzLDvmrO28 @DrNickKennedy @JamesGoodhand @tari
Breakdown of the questions asked and answered in this dataset Full publications available online https://t.co/iXRo1DbD4x https://t.co/GXY55T6ON1 https://t.co/LAthsxIslQ 20 minute video with full explanation here https://t.co/h5uCHsnHYA https://t.co/LXIob
RT @stephenfloor: Shout out to folks on TNF blockers, these drugs reduced antibody titers after vaccination: https://t.co/NUec5S2hHJ. Now a…
RT @stephenfloor: Shout out to folks on TNF blockers, these drugs reduced antibody titers after vaccination: https://t.co/NUec5S2hHJ. Now a…
Shout out to folks on TNF blockers, these drugs reduced antibody titers after vaccination: https://t.co/NUec5S2hHJ. Now antibody levels are linked to breakthrough cases in vaccinated people: https://t.co/yIX1Nn2n0x. Be careful out there ♥️
RT @ibdtweets: What does this study mean? Here is the summary of this recently published study on INFLIXIMAB and COVID-19 antibody response…
RT @Anja_InnatOss: 1/3 Dagelijks krijgen we vragen over afweer tegen corona en vaccinatie bij gebruik van anti-TNF, prednison, methotrexaat…
RT @Anja_InnatOss: 1/3 Dagelijks krijgen we vragen over afweer tegen corona en vaccinatie bij gebruik van anti-TNF, prednison, methotrexaat…
RT @ibdtweets: What does this study mean? Here is the summary of this recently published study on INFLIXIMAB and COVID-19 antibody response…
RT @ibdtweets: What does this study mean? Here is the summary of this recently published study on INFLIXIMAB and COVID-19 antibody response…
Building up on this is another VA study to assess effectiveness of SARS-COV2 vaccine in IBD patients with immunosupression. Summary below 👇 https://t.co/tS8V677QSD
RT @ibdtweets: How are you describing this study to your patients ? @DCharabaty @IBD_Afzali @MLongMD @UmaMahadevanIBD @IBD_Houston @GilMelm…
How are you describing this study to your patients ? @DCharabaty @IBD_Afzali @MLongMD @UmaMahadevanIBD @IBD_Houston @GilMelmedMD @doc_ibd @GilMelmedMD @ibddocmaria @ibddoctor @SimonHongMD @Badr_AlBawardy @SchairerIBDMD @JasonHouMD @AndresYarur @waqqasafif
What does this study mean? Here is the summary of this recently published study on INFLIXIMAB and COVID-19 antibody response https://t.co/zlFBmZgRjW
Studies over effect van gebruik van immunosuppressiva op COVID-19 vaccinatie zullen hopelijke snel meer duidelijkheid geven @rorydevries @MarionKoopmans @MarcBonten @Regeneron @MSDNederland @Genmab @AcertaNL @AstraZenecaNL @BioNTech_Group
1/3 Dagelijks krijgen we vragen over afweer tegen corona en vaccinatie bij gebruik van anti-TNF, prednison, methotrexaat, rituximab, azathioprine etc. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https:/
RT @thecrohniegal: @IoannaCBC could you bring attn to large scale UK peer review study (@clarityibd) that confirms those with #autoimmunedi…
RT @thecrohniegal: @IoannaCBC could you bring attn to large scale UK peer review study (@clarityibd) that confirms those with #autoimmunedi…
@SLPang @thecrohniegal @CTVNews @BNeustaeter @clarityibd @ONThealth @GovCanHealth It's so frustrating to see scientific studies so poorly covered in media. They quoted a non-peer-reviewed paper but omitted a published, peer-reviewed study on IBD patients:
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
②Vedorizumabに比べ、infliximab治療を受けたIBD患者ではCOVIDに対する免疫応答やワクチン効果が減弱する https://t.co/y5cMrqNmig https://t.co/YefUQkZG1h
Here's a research article on infliximab/remicade and covid vaccination. Most infliximab patients did not generate sufficient antibodies after vaccination. 4/n https://t.co/TfjsMh5aaI
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/e5axFxGpiG
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/a5CP6aWLVZ
@MillaAugestine @epi_twit A friend sent me this... https://t.co/pfVkfTucqu
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
Patienten mit #CED auf #Infliximab haben in dieser @Gut_BMJ Studie abgeschwächte Impfantwort gezeigt https://t.co/5rzdN3PndH
RT @thecrohniegal: 2. Large scale study conducted in UK w/ #IBD patients (see @ClarityIBD) confirms those taking medications that suppress…
💥For the individual anti-TNF-treated patient, lower rates of seroconversion and reduced anti- #SARSCoV2 antibody reactivity levels may increase their susceptibility to recurrent #COVID-19. https://t.co/UYmYmsxT9T @Gut_BMJ
RT @DuarteSilva_M: Despite similar rates of infection and symptomatic disease, patients treated with anti-TNF produces less antibodies agai…
RT @DuarteSilva_M: Despite similar rates of infection and symptomatic disease, patients treated with anti-TNF produces less antibodies agai…
RT @DuarteSilva_M: Despite similar rates of infection and symptomatic disease, patients treated with anti-TNF produces less antibodies agai…
RT @DuarteSilva_M: Despite similar rates of infection and symptomatic disease, patients treated with anti-TNF produces less antibodies agai…
RT @DuarteSilva_M: Despite similar rates of infection and symptomatic disease, patients treated with anti-TNF produces less antibodies agai…
Despite similar rates of infection and symptomatic disease, patients treated with anti-TNF produces less antibodies against SARS-CoV-2 than vedolizumab treated patients. @Gut_BMJ #IBD https://t.co/a9UDD0gJ7H
This is an extremely helpful and reassuring discussion of this article, which suggested that the mRNA vaccines may not be effective for those of us on immunosuppressive drugs. The key point is that the immune response is fully effective after the second d
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTtnsK @bmj_c…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
RT @KralJan: The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T2…
The latest research shows that Infliximab is associated with attenuated serological responses to #SARSCoV2 🔥🔥👇 https://t.co/T26iWvGpN3 #UEGambassador #IBD #COVID19 @my_ueg @Gut_BMJ @KM_Pawlak @drdalbir @stevenbollipo @RodriguezParra_ @RobertoSimonsMD @Cha
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @ellearee: @MelisaGillett @DawnMGibson Did you see this? Some interesting info... https://t.co/krBHrWX6C0
@MelisaGillett @DawnMGibson Did you see this? Some interesting info... https://t.co/krBHrWX6C0
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @TessaJeanMiller: Good info here if (like me!) you’re concerned about how infliximab affects the COVID vaccine
RT @SWexner: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/cZ5yJTtnsK @bmj_c…
This is really important!
RT @TessaJeanMiller: Good info here if (like me!) you’re concerned about how infliximab affects the COVID vaccine https://t.co/vVAKpOnhp6
RT @TessaJeanMiller: Good info here if (like me!) you’re concerned about how infliximab affects the COVID vaccine
Thank you, @ibdmd! A reassuring breakdown of the way that NYT article misrepresented research on vaccine antibody response in immunocompromised IBD patients on Infliximab.
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…
RT @IBDMD: A brief Tweetorial to clarify the NYT article from 15 April and further explain/clarify the Kennedy paper (that is in press in G…